HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Dhib-Jalbut Selected Research

Therapeutics

11/2016Predictive cytokine biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis.
9/2010Overlapping and distinct mechanisms of action of multiple sclerosis therapies.
12/2002Effect of combined IFNbeta-1a and glatiramer acetate therapy on GA-specific T-cell responses in multiple sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Dhib-Jalbut Research Topics

Disease

8Multiple Sclerosis
11/2016 - 07/2000
1Relapsing-Remitting Multiple Sclerosis
11/2016
1Neurodegenerative Diseases (Neurodegenerative Disease)
02/2004
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
07/2000
1Autoimmune Diseases (Autoimmune Disease)
07/2000
1Disease Progression
07/2000

Drug/Important Bio-Agent (IBA)

4Glatiramer Acetate (Copaxone)FDA Link
11/2016 - 09/2002
2CytokinesIBA
11/2016 - 07/2000
1Pharmaceutical PreparationsIBA
11/2016
1Biomarkers (Surrogate Marker)IBA
11/2016
1Interleukin-4 (Interleukin 4)IBA
07/2007
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
04/2005
1Brain-Derived Neurotrophic Factor (BDNF)IBA
02/2004
1Nerve Growth Factors (Neurotrophins)IBA
02/2004
1Interferon-betaIBA
12/2002
1Acetates (Acetic Acid Esters)FDA Link
08/2001
1Therapeutic UsesIBA
07/2000
1Interleukin-12 (IL 12)IBA
07/2000

Therapy/Procedure

3Therapeutics
11/2016 - 12/2002